These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29464917)

  • 1. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Sano T; Ikeda T
    Clin Exp Hypertens; 2020 Aug; 42(6):539-544. PubMed ID: 32009474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension.
    Kanegae K; Hiroshige K; Suda T; Iwamoto M; Ohta T; Nakashima Y; Ohtani A
    Int J Artif Organs; 1999 Dec; 22(12):798-804. PubMed ID: 10654875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
    Matsuoka H; Kuwajima I; Shimada K; Mitamura H; Saruta T
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):806-14. PubMed ID: 24119112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension.
    Paterna S; Parrinello G; Di Pasquale P; Torres D; La Rocca G; Antona R; Vernuccio L; Fornaciari E; Tarantino A; Piccione E; Fasullo S; Licata G
    Adv Ther; 2007; 24(6):1260-70. PubMed ID: 18165208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
    Yamazaki D; Shimura Y; Enjoji Y; Nishinaga M; Kanmatuse K; Endo M
    J Cardiol; 2020 Apr; 75(4):394-399. PubMed ID: 31627998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency-domain heart rate variability in 24-hour Holter recordings: role of spectral method to assess circadian patterns and pharmacological autonomic modulation.
    Badilini F; Maison-Blanche P; Champomier P; Provost JC; Coumel P; Milon H
    J Electrocardiol; 2000 Apr; 33(2):147-57. PubMed ID: 10819408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bisoprolol on heart rate variability in heart failure.
    Pousset F; Copie X; Lechat P; Jaillon P; Boissel JP; Hetzel M; Fillette F; Remme W; Guize L; Le Heuzey JY
    Am J Cardiol; 1996 Mar; 77(8):612-7. PubMed ID: 8610612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
    Momomura SI; Saito Y; Yasumura Y; Yamamoto K; Sakata Y; Daimon M; Kinugawa K; Okamoto H; Dohi N; Komuro I
    Circ J; 2017 Dec; 82(1):141-147. PubMed ID: 28768917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Transdermal Bisoprolol Patch with Oral Bisoprolol Fumarate Administration as a Therapeutic Agent for Idiopathic Frequent Premature Ventricular Contractions.
    Shinohara M; Wada R; Yao S; Yano K; Akitsu K; Koike H; Kinoshita T; Yuzawa H; Suzuki T; Fujino T; Ikeda T
    Int Heart J; 2020 May; 61(3):510-516. PubMed ID: 32418969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of Transdermal Patch of Bisoprolol for Paroxysmal Atrial Fibrillation after Open Heart Surgery].
    Yamamoto K; Yamada T; Hamuro M; Kawatou M; Enomoto S
    Kyobu Geka; 2017 Nov; 70(12):971-977. PubMed ID: 29104194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches.
    Sezai A; Sekino H; Taoka M; Osaka S; Tanaka M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37240955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.